Maxcyte (MXCT) FCF Margin (2020 - 2025)
Historic FCF Margin for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to 113.6%.
- Maxcyte's FCF Margin fell 548500.0% to 113.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 119.78%, marking a year-over-year decrease of 732300.0%. This contributed to the annual value of 75.75% for FY2024, which is 142700.0% down from last year.
- Latest data reveals that Maxcyte reported FCF Margin of 113.6% as of Q3 2025, which was down 548500.0% from 122.68% recorded in Q2 2025.
- In the past 5 years, Maxcyte's FCF Margin ranged from a high of 0.42% in Q4 2023 and a low of 144.99% during Q1 2025
- Over the past 5 years, Maxcyte's median FCF Margin value was 76.22% (recorded in 2021), while the average stood at 77.44%.
- Over the last 5 years, Maxcyte's FCF Margin had its largest YoY gain of 681800bps in 2024, and its largest YoY loss of -920800bps in 2024.
- Over the past 5 years, Maxcyte's FCF Margin (Quarter) stood at 20.51% in 2021, then tumbled by -225bps to 66.66% in 2022, then surged by 101bps to 0.42% in 2023, then crashed by -21855bps to 91.66% in 2024, then decreased by -24bps to 113.6% in 2025.
- Its FCF Margin stands at 113.6% for Q3 2025, versus 122.68% for Q2 2025 and 144.99% for Q1 2025.